Parrilla Francisco José, Morán Indalecio, Roche-Campo Ferran, Mancebo Jordi
Intensive Care Unit, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Semin Respir Crit Care Med. 2014 Aug;35(4):431-40. doi: 10.1055/s-0034-1382155. Epub 2014 Aug 11.
Chronic obstructive pulmonary disease (COPD) is characterized by expiratory flow limitation (EFL) due to progressive airflow obstruction. The various mechanisms that cause EFL are central to understanding the physiopathology of COPD. At the end of expiration, dynamic inflation may occur due to incomplete emptying the lungs. This "extra" volume increases the alveolar pressure at the end of the expiration, resulting in auto-positive end-expiratory pressure (PEEP) or PEEPi. Acute exacerbations of COPD may result in increased airway resistance and inspiratory effort, further leading to dynamic hyperinflation. COPD exacerbations may be triggered by environmental exposures, infections (viral and bacterial), or bronchial inflammation, and may result in worsening respiratory failure requiring mechanical ventilation (MV). Acute exacerbations of COPD need to be distinguished from other events such as cardiac failure or pulmonary emboli. Strategies to treat acute respiratory failure (ARF) in COPD patients include noninvasive ventilation (NIV), pressure support ventilation, and tracheal intubation with MV. In this review, we discuss invasive and noninvasive techniques to address ARF in this patient population. When invasive MV is used, settings should be adjusted in a way that minimizes hyperinflation, while providing reasonable gas exchange, respiratory muscle rest, and proper patient-ventilator interaction. Further, weaning from MV may be difficult in these patients, and factors amenable to pharmacological correction (such as increased bronchial resistance, tracheobronchial infections, and heart failure) are to be systematically searched and treated. In selected patients, early use of NIV may hasten the process of weaning from MV and improve outcomes.
慢性阻塞性肺疾病(COPD)的特征是由于进行性气流阻塞导致呼气流量受限(EFL)。导致EFL的各种机制是理解COPD病理生理学的核心。在呼气末期,由于肺排空不完全可能会发生动态充气。这种“额外”的容积会增加呼气末期的肺泡压力,导致内源性呼气末正压(PEEP)或内源性PEEP(PEEPi)。COPD急性加重可能导致气道阻力增加和吸气努力增加,进而导致动态肺过度充气。COPD加重可能由环境暴露、感染(病毒和细菌)或支气管炎症引发,并可能导致呼吸衰竭恶化,需要机械通气(MV)。COPD急性加重需要与其他事件如心力衰竭或肺栓塞相鉴别。治疗COPD患者急性呼吸衰竭(ARF)的策略包括无创通气(NIV)、压力支持通气以及气管插管并进行MV。在本综述中,我们讨论针对该患者群体解决ARF的有创和无创技术。当使用有创MV时,应调整设置以尽量减少肺过度充气,同时提供合理的气体交换、呼吸肌休息以及适当的人机交互。此外,这些患者撤机可能困难,需要系统地查找并治疗可通过药物纠正的因素(如支气管阻力增加、气管支气管感染和心力衰竭)。在选定的患者中,早期使用NIV可能会加速撤机过程并改善预后。